MA47112A - METHODS FOR TREATING IRRITABLE COLON SYNDROME WITH MODIFIED OR DELAYED LINACLOTIDE RELEASE FORMULATIONS - Google Patents
METHODS FOR TREATING IRRITABLE COLON SYNDROME WITH MODIFIED OR DELAYED LINACLOTIDE RELEASE FORMULATIONSInfo
- Publication number
- MA47112A MA47112A MA047112A MA47112A MA47112A MA 47112 A MA47112 A MA 47112A MA 047112 A MA047112 A MA 047112A MA 47112 A MA47112 A MA 47112A MA 47112 A MA47112 A MA 47112A
- Authority
- MA
- Morocco
- Prior art keywords
- delayed
- modified
- methods
- release formulations
- treating irritable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662437566P | 2016-12-21 | 2016-12-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA47112A true MA47112A (en) | 2019-10-30 |
Family
ID=61022424
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA047112A MA47112A (en) | 2016-12-21 | 2017-12-21 | METHODS FOR TREATING IRRITABLE COLON SYNDROME WITH MODIFIED OR DELAYED LINACLOTIDE RELEASE FORMULATIONS |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3558337A1 (en) |
| JP (2) | JP2020512292A (en) |
| CN (1) | CN110475564A (en) |
| AU (1) | AU2017379082A1 (en) |
| BR (1) | BR112019012689A2 (en) |
| CA (1) | CA3048195A1 (en) |
| EA (1) | EA201991531A1 (en) |
| MA (1) | MA47112A (en) |
| MX (2) | MX2019007574A (en) |
| WO (1) | WO2018119191A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3979992A4 (en) * | 2019-06-10 | 2023-09-13 | Ironwood Pharmaceuticals, Inc. | Treatment of abdominal pain associated with diarrhea-predominant irritable bowel syndrome |
| CA3238619A1 (en) * | 2021-11-29 | 2023-06-01 | Michael Gerber | Pharmaceutical compositions for the treatment of visceral pain |
| WO2023196821A2 (en) * | 2022-04-04 | 2023-10-12 | Thomas Jefferson University | Targeting neuropod cell gucy2c to control visceral pain and appetite |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7304036B2 (en) | 2003-01-28 | 2007-12-04 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| US7371727B2 (en) | 2003-01-28 | 2008-05-13 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| HUE049023T2 (en) | 2008-08-15 | 2020-08-28 | Ironwood Pharmaceuticals Inc | Linaclotide-containing formulations for oral administration |
| WO2011020054A1 (en) * | 2009-08-13 | 2011-02-17 | Ironwood Pharmaceuticals Inc. | Method for modulating the pharmacodynamic effect of orally administered guanylate cyclase receptor agonists |
| UA108636C2 (en) | 2010-02-17 | 2015-05-25 | PEPTIDE | |
| RS59978B1 (en) * | 2010-08-11 | 2020-03-31 | Ironwood Pharmaceuticals Inc | Stable formulations of linaclotide |
| DK2776055T3 (en) * | 2011-08-17 | 2017-03-06 | Ironwood Pharmaceuticals Inc | TREATMENTS FOR GASTROINTESTINAL DISORDERS |
| CA2898362C (en) * | 2013-01-15 | 2020-09-01 | Ironwood Pharmaceuticals, Inc. | Gastro-retentive sustained-release oral dosage form of a bile acid sequestrant |
| UA119335C2 (en) * | 2013-12-11 | 2019-06-10 | Айронвуд Фармасьютикалз, Інк. | Delayed release compositions of linaclotide |
| ES2868873T3 (en) * | 2015-06-05 | 2021-10-22 | Ironwood Pharmaceuticals Inc | Modified or targeted release formulations of linaclotide |
-
2017
- 2017-12-21 WO PCT/US2017/067814 patent/WO2018119191A1/en unknown
- 2017-12-21 CN CN201780087073.0A patent/CN110475564A/en active Pending
- 2017-12-21 AU AU2017379082A patent/AU2017379082A1/en active Pending
- 2017-12-21 CA CA3048195A patent/CA3048195A1/en active Pending
- 2017-12-21 JP JP2019533167A patent/JP2020512292A/en active Pending
- 2017-12-21 MA MA047112A patent/MA47112A/en unknown
- 2017-12-21 BR BR112019012689-9A patent/BR112019012689A2/en unknown
- 2017-12-21 MX MX2019007574A patent/MX2019007574A/en unknown
- 2017-12-21 EA EA201991531A patent/EA201991531A1/en unknown
- 2017-12-21 EP EP17833050.2A patent/EP3558337A1/en active Pending
-
2019
- 2019-06-21 MX MX2023008839A patent/MX2023008839A/en unknown
-
2022
- 2022-04-27 JP JP2022073214A patent/JP2022093472A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN110475564A (en) | 2019-11-19 |
| WO2018119191A1 (en) | 2018-06-28 |
| JP2020512292A (en) | 2020-04-23 |
| CA3048195A1 (en) | 2018-06-28 |
| EP3558337A1 (en) | 2019-10-30 |
| AU2017379082A1 (en) | 2019-07-04 |
| BR112019012689A2 (en) | 2019-11-19 |
| MX2019007574A (en) | 2019-09-04 |
| JP2022093472A (en) | 2022-06-23 |
| EA201991531A1 (en) | 2019-11-29 |
| MX2023008839A (en) | 2023-08-14 |
| WO2018119191A9 (en) | 2018-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA43380A (en) | MODIFIED CHEMERICAL RECEPTORS AND ASSOCIATED COMPOSITIONS AND PROCESSES | |
| MA45779A (en) | POLYPEPTIDES IMMUNOMDULATORS AND RELATED COMPOSITIONS AND PROCESSES | |
| MA50569A (en) | FILLING-FINISHING UNITS AND ASSOCIATED PROCESSES | |
| MA43711A (en) | L-GLUFOSINATE PRODUCTION PROCESSES | |
| MA52506A (en) | METHODS FOR TREATING INFECTIONS WITH NIPAH VIRUSES | |
| MA45426A (en) | TRANSDUCTION PROCESSES, KITS, AGENTS AND APPARATUS | |
| DK3329002T3 (en) | TRANSTHYRETIN (TTR) IRNA COMPOSITIONS AND METHODS FOR USING IT FOR THE TREATMENT OR PREVENTION OF TTR-ASSOCIATED DISEASES | |
| EP3188741A4 (en) | Compositions and methods for the treating an inflammatory disease or disorder | |
| MA40824A (en) | MODIFIED VIRUS TYPE CMV PARTICLES | |
| IL266162A (en) | Adeno-associated virus purification methods | |
| MA46865A (en) | CARYOPHYLLENE COMPOSITIONS, APPARATUS AND PROCESSES | |
| IL251606B (en) | Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease | |
| MA47112A (en) | METHODS FOR TREATING IRRITABLE COLON SYNDROME WITH MODIFIED OR DELAYED LINACLOTIDE RELEASE FORMULATIONS | |
| MA45574A (en) | PROCEDURES FOR THE TREATMENT OF INJURIES OR CONDITIONS RELATED TO CNS EMA | |
| FR3055468B1 (en) | DEVICE FOR PROCESSING PARTS | |
| BR112017021850A2 (en) | clusterin specific isoforms detection | |
| BR112016024667A2 (en) | improved coating compositions and processes for the manufacture thereof | |
| MA41961A (en) | SOLID ADSORBENT REGENERATION PROCESSES | |
| DK3331610T3 (en) | Agents for the treatment of glioma | |
| MA52920A (en) | COMPOSITIONS AND METHODS RELATING TO PYRIDINOYLPIPERIDINE 5-HT1F AGONISTS | |
| DK3096775T3 (en) | SOCS mimetics for the treatment of diseases | |
| MA46711A (en) | POLYSACCHARIDE AND PROCESSES | |
| MA43682A (en) | LACTOSE INTOLERANCE TREATMENT METHODS | |
| JOP20140008B1 (en) | Use of alpha 7 acetylcholine receptor agonists | |
| MA49688A (en) | MYELODYSPLASIC SYNDROME TREATMENT METHODS |